Proteomics takes stem cell analyses to another level
Article Abstract:
A method is developed for assaying post-translational modifications during stem cell expansion and differentiation in a high-throughput fashion and is applied to study the growth factor-regulated differentiation of human mesenchymal stem (hMS) cells. It was established that hMS cells exposed to two distinct growth factors, epidermal growth factor (EGF) and the platelet-derived growth factors (PDGF), show different patterns of tyrosine phosphorylation (pTyr).
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
On the road to therapeutic cloning
Article Abstract:
The research based on human embryonic stem cells shows that it is possible to create human embryonic cells using the cells of the patient as a source, but many problems related to reprogramming without induction of abnormalities, control of the stem cell proliferation and other problems need to be overcome. The development of embryonic stem cells from cloned human embryos raises concerns regarding the moral and ethical issues.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype
Article Abstract:
Direct assessment of embryonic phenotypes by the tetraploid aggregation method is discussed.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Trading halts and market activity: an analysis of volume at the open and the close. Insider trading in the OTC market
- Abstracts: When PW's concerns failed to move the Bank. Incorporation and the damages ceiling. A sharing, caring banking system
- Abstracts: Stable antibody expression at therapeutic level using the 2A peptide. Site-specific PEGylation of a lysine-deficient TNF-alpha with full bioactivity